97N-0497 Allogeneic Peripheral and Placental/ Umbilical Cord Blood
C 15 American Association of Blood Banks Vol#: 4
97P-0078 Recognized the Term "Soymilk" as the Established Common of U
ANS 1 HFW-14 to Honorable Harry M. reid Vol#: 1
99P-1864 Reclassify Constrained Hip Prosthesis Metal/Polymer
C 2 Heller Ehrman White & McAuliffe, LLP Vol#: 3
C 3 American Academy of Orthopaedic Surgeons Vol#: 3
99P-2148 Label or Labeling of food ingredients and regulation
ANS 2 HFS-800 to Ms. Fran Stevens Vol#: 1
99P-5198 Request amendment of the definition of milk
C 4 David Lauer Vol#: 1
00D-1538 Electronic Records; Electronic Signatures, Validation
C 3 Genzyme Corporation Vol#: 5
00N-1396 Bioengineered Foods Consumed By Humans or Animals
C 9176 Caitlin Bidinger Vol#: 401
C 9177 Aaron Infante-Levy Vol#: 401
00P-0586 Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
C 29 David Lauer Vol#: 2
01D-0368 Submitting Marketing Applications according to ICH/CTD Forma
C 7 Hecker & Associates Vol#: 1
01D-0489 Establishment & Operation of Clinical Trial Monitoring Comm
C 1 George Washington University Vol#: 1
01H-0065 Civil Money Penalty for First Check Home Drug Test Devices
MO 11 Worldwide Medical Corporation Vol#: 1
01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA
C 10 Bayer Corporation Vol#: 1
01N-0397 Transportation Safety & Potentially Sedating or Impairing
C 6 Center for Disease Control & Prevention Vol#: 2
01N-0450 Prescription Drug User Fee Act (PDUFA)
APE 1 General Accounting Office Vol#: 2
APE 2 Patton Boggs, LLP Vol#: 2
APE 3 Vince Ventimiglia Vol#: 2
APE 4 Pharmaceutical Executive Magazine Vol#: 2
APE 5 National Breast Cancer Coalition Vol#: 2
APE 6 Children's Cause, Inc. Vol#: 2
APE 7 A.G. Edwards & Sons, Inc. Vol#: 2
APE 8 McNeil Consumer & Specialty Pharm Vol#: 2
APE 10 Ovarian Cancer National Alliance Vol#: 2
APE 11 Video On Location, Inc. Vol#: 2
APE 12 Merck Research Laboratories Vol#: 2
APE 13 National Assn of Health Underwriters Vol#: 2
APE 14 Baxter Healthcare Vol#: 2
APE 15 BNA Health Care Policy Report Vol#: 2
APE 16 American Medical Assn Vol#: 2
APE 17 Washington Health Advocates Vol#: 2
APE 18 Philadelphia Distric Office Vol#: 2
APE 19 Bristol-Myers Squibb Vol#: 2
APE 20 Pharmaceutical Executive Magazine Vol#: 2
APE 22 BioCentury Publications Vol#: 2
APE 23 Gregory K. Frykman Vol#: 2
APE 24 Sigma-tau Research, Inc. Vol#: 2
APE 25 Patton Boggs, LLP Vol#: 2
APE 26 Johnson & Johnson Vol#: 2
APE 28 Eli Lilly and Company Vol#: 2
LST 3 Agenda for PDUFA Public Meeting 12/7/01 Vol#: 2
LST 4 PDUFA Registration for 12/7/01 meeting Vol#: 2
LST 5 PDUFA On-Site Registration 12/07/01 mtg Vol#: 2
TS 3 BlueCross BlueShield Assn Vol#: 2
TS 4 Biotechnology Industry Organization Vol#: 2
TS 5 Consumer Federation of America Vol#: 2
TS 6 National Organization for Rare Disorders Vol#: 2
TS 7 American Pharmaceutical Assn Vol#: 2
TS 8 National Center for Policy Research for Vol#: 2
TS 9 Academy of Managed Care Pharmacy Vol#: 2
TS 11 Tufts University Vol#: 2
TS 13 National Women's Health Network Vol#: 2
01N-0464 Vaccine Adverse Event Reporting System
C 1 Missouri Department of Health and Senior Vol#: 1
01N-0496 Patient Profile Viewer
N 1 Vol#: 1
01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
LET 3 HFD-560 to David A. Grimes, M.D. Vol#: 10
01P-0323 Not rely on non-public filings to approve an innovator NDA;
C 1 Generic Pharmaceutical Assn Vol#: 1
01P-0443 Estrogen & progestin drug info available to the public is "M
PDN 1 HFD-001 to Gail Elbek Vol#: 1
01P-0549 Determination of Nitroglycerin Aerosol (sublingual)
CP 1 Lachman Consultant Services, Inc. Vol#: 1
01P-0560 Refrain Approval of Any Buprenorphine Product
CP 1 Hogan & Hartson, LLP Vol#: 1
01V-0457 XiScan Model 6000 diagnostic X-Ray System
VRA 1 HFZ-300 to XiTech, Inc. Vol#: 1